Inventor · disambiguated record
Andrew V. Samant
Also filed as: SAMANT ANDREW · SAMANT ANDREW V
8 granted patents·7 pending applications·8 citations·filing 2020–2024
79Inventor score
Files withJANSSEN PHARMACEUTICA NV15
Top patents by PatentIndex Score
15 records- 0189US11530210B2Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·2 cites·129 claims
- 0289US11161846B2Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 0387US11897872B2Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 13, 2024·1 cites·15 claims
- 0485US11802111B2Cyclobutyl amide monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 31, 2023·1 cites·23 claims
- 0582US11787798B2Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 17, 2023·1 cites·18 claims
- 0682US11505546B2Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 22, 2022·1 cites·18 claims
- 0777US2025136598A1Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0875US2024239776A1Azaspirocycles as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0973US12172997B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 1071US2024208902A1Cyclobutyl amide monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1169US2024092781A1Aryl piperidines as monoacylglycerol lipase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1267US2023045960A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1358US2022274984A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1454US11618750B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 4, 2023·0 cites·124 claims
- 1553US2023339970A1Casein kinase 1 delta modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →